Phenoxodiol Overview: A Research Opportunity for Women With Recurrent Ovarian Cancer
Marshall Edwards explains how a new investigational drug called phenoxodiol is restoring sensitivity to the cancer cells of patients that have become resistant to standard chemotherapy drugs. Phenoxodiol has not yet been approved by the regulatory agencies, such as the US Food and Drug Administration (FDA), for commercial distribution. Phenoxodiol is a pill taken by mouth.